Design
Review
Authors
Loading...
Supports ACE inhibitor or calcium antagonist use to slow hypertensive renal damage; leaves open optimal regimens pending contemporary randomized data.
Key points are not available for this paper at this time.
Ritz et al. (1993) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: